Century Therapeutics to Present at Global Investment Conference

Century Therapeutics

PHILADELPHIA, PACentury Therapeutics, Inc. (NASDAQ: IPSC) announced that CEO Brent Pfeiffenberger, Pharm.D., will deliver a company presentation at the H.C. Wainwright 27th Annual Global Investment Conference. The event takes place September 9-10, 2025, in New York, NY, where members of Century’s management team will also meet with investors.

An on-demand webcast of the presentation will be available beginning September 5, 2025, and remain accessible on the company’s website for at least 30 days.

Century Therapeutics is a clinical-stage biotechnology company specializing in developing iPSC-derived cell therapies for autoimmune diseases and cancers. Leveraging advances in cellular reprogramming, genetic engineering, and manufacturing, the company aims to create off-the-shelf therapies designed to improve patient access and outcomes.

READ:  Stateside Vodka Secures Naming Rights for South Philly’s Top Entertainment Hub

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.